An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
Article in Clinical Drug Investigation (May 2020)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Clinical Drug Investigation (May 2020)
Article in Expert Opinion on Drug Safety (April 2020)
Article in Journal of Medical Economics (May 2019)